Medline (MDLN) revenue: $28.4B
Medline reported $28.4B of revenue for the year ended Dec 31, 2025, up 11.5% from $25.5B a year earlier.
From Medline's filings with the SEC · Read the filing · MDLN stock page
Medline revenue by year
#154 of 3,623 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $28.4B | +11% |
| Dec 31, 2024 | $25.5B | +10% |
| Dec 31, 2023 | $23.2B | – |
Revenue of similar companies
Companies in the same industry as Medline, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Medline | $28.4B | Dec 31, 2025 |
| Stryker | $25.1B | Dec 31, 2025 |
| 3M | $24.9B | Dec 31, 2025 |
| Becton Dickinson | $21.8B | Sep 30, 2025 |
| Boston Scientific | $20.1B | Dec 31, 2025 |
| Baxter International | $11.2B | Dec 31, 2025 |
| Solventum | $8.3B | Dec 31, 2025 |
Questions and answers
What is Medline's revenue?
Medline reported $28.4B of revenue for the year ended Dec 31, 2025, up 11.5% from $25.5B a year earlier.
Numbers as reported in Medline's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology